tirzepatide vs glp-1 glp 1 Tirzepatide vs. Semaglutide: Key Differences & Benefits Tirzepatide vs liraglutide: complete comparison
Description
SELECT trial cardiovascular data
The GLP-1R is expressed in many tissues, including the heart, brain, kidney, liver and immune system
It is not FDA-approved as a finished product but remains legal under patient-specific compounding rules in April 2026 via federal court injunctions
This translates into $126 billion in sales by 2029, a 2023-2029 sales CAGR of 30%
